Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes.

被引：0
|
作者：
Pender, Alexandra
Hughesman, Curtis
Law, Elaine
Kristanti, Amadea
McNeil, Kelly
Tucker, Tracy
Bosdet, Ian
Young, Sean
Laskin, Janessa J.
Karsan, Aly
Yip, Stephen
Ho, Cheryl
机构：
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
[4] BC Canc, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9080
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
    Yamaguchi, Ou
    Kasahara, Norimitsu
    Soda, Hiroshi
    Imai, Hisao
    Naruse, Ichiro
    Yamaguchi, Hiroyuki
    Itai, Miki
    Taguchi, Kohei
    Uchida, Megumi
    Sunaga, Noriaki
    Maeno, Toshitaka
    Minato, Koichi
    Tomono, Hiromi
    Ogawara, Daiki
    Mukae, Hiroshi
    Miura, Yu
    Shiono, Ayako
    Mouri, Atsuto
    Kagamu, Hiroshi
    Kaira, Kyoichi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
    Ou Yamaguchi
    Norimitsu Kasahara
    Hiroshi Soda
    Hisao Imai
    Ichiro Naruse
    Hiroyuki Yamaguchi
    Miki Itai
    Kohei Taguchi
    Megumi Uchida
    Noriaki Sunaga
    Toshitaka Maeno
    Koichi Minato
    Hiromi Tomono
    Daiki Ogawara
    Hiroshi Mukae
    Yu Miura
    Ayako Shiono
    Atsuto Mouri
    Hiroshi Kagamu
    Kyoichi Kaira
    Scientific Reports, 13
  • [33] KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA
    Del Re, M.
    Tiseo, M.
    D'Incecco, A.
    Camerini, A.
    Petrini, I.
    Lucchesi, M.
    Inno, A.
    Spada, D.
    Bordi, P.
    Vasile, E.
    Citi, V.
    Malpeli, G.
    Testa, E.
    Gori, S.
    Falcone, A.
    Amoroso, D.
    Chella, A.
    Cappuzzo, F.
    Ardizzoni, A.
    Scarpa, A.
    Danesi, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 83 - 83
  • [34] Circulating tumor DNA as biomarker in mutant malignant melanoma
    Braune, J.
    Glaser, L.
    Philipp, U.
    von Bubnoff, D.
    Duyster, J.
    von Bubnoff, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 124 - 124
  • [35] Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC
    Modlin, L. A.
    Bratman, S. V.
    Newman, A. M.
    Eclov, N. C. W.
    Neal, J. W.
    Wakelee, H. A.
    Shrager, J. B.
    Loo, B. W.
    Alizadeh, A. A.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S812 - S812
  • [36] Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study
    Denis, Marc G.
    Lafourcade, Marie-Pierre
    Le Garff, Gwenaelle
    Dayen, Charles
    Falchero, Lionel
    Thomas, Pascal
    Locher, Chrystele
    Oliviero, Gerard
    Licour, Muriel
    Reck, Martin
    Normanno, Nicola
    Molinier, Olivier
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1370 - 1378
  • [37] Monitoring immunotherapy outcomes with circulating tumor DNA
    Goldberg, Sarah B.
    Patel, Abhijit A.
    IMMUNOTHERAPY, 2018, 10 (12) : 1023 - 1025
  • [38] Circulating free tumor DNA and colorectal cancer
    Lecomte, T.
    Ceze, N.
    Dorval, E.
    Laurent-Puig, P.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (12): : 662 - 681
  • [39] Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinoma
    Rosell, Rafael
    Karachaliou, Niki
    LANCET RESPIRATORY MEDICINE, 2018, 6 (09): : 649 - 651
  • [40] Liquid biopsy in NSCLC: EpCAM plus and EpCAM-circulating tumor cells, tumor derived extracellular vesicles and cell-free circulating tumor DNA
    de Wit, Sanne
    Tamminga, Menno
    Swennenhuis, Joost F.
    Zeune, Leonie L.
    Heitzer, Ellen
    Speicher, Michael
    Hiltermann, T. Jeroen N.
    Terstappen, Leon W. M. M.
    Groen, Harry J. M.
    CANCER RESEARCH, 2017, 77
12345